Form 8-K - Current report:
SEC Accession No. 0001104659-19-029775
Filing Date
2019-05-15
Accepted
2019-05-15 17:01:44
Documents
3
Period of Report
2019-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-10034_18k.htm 8-K 26046
2 EX-99.1 a19-10034_1ex99d1.htm EX-99.1 12634
3 GRAPHIC g100341mmi001.jpg GRAPHIC 3139
  Complete submission text file 0001104659-19-029775.txt   44245
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 19829418
SIC: 2834 Pharmaceutical Preparations